GlassScriptPhysician profile
Asha Ayub
NPI 1790362705
$2,587.29
in general payments reported to CMS, 2019-2025
8 companies · $1,643 in 2025
The $1,643 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.36 · 2023: $719 · 2024: $197 · 2025: $1,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Travel and Lodging: $953 · Grant: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.15 |
| Travel and Lodging | $953.22 |
| Grant | $150.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,861.54 | 2023-2025 | Ams 700, Advantage System, Ams Ambicor |
| Innovation Technologies INC | $233.14 | 2024-2025 | Irrisept |
| Urogen Pharma, INC. | $164.78 | 2023 | Jelmyto |
| Ferring Pharmaceuticals INC. | $158.04 | 2025 | Adstiladrin |
| Calyxo, INC. | $121.40 | 2025 | Cvac Aspiration System |
| Convatec INC. | $19.03 | 2024 | |
| Abbvie INC. | $17.24 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Ayub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.